Therefore, this study was aimed to understand the regulatory roles of radiation‐induced USF‐1, its targeting by HDAC inhibitors, and to identify the novel mechanisms underlying the reversal of radioresistance, leading to radiosensitizing effects of these inhibitors in prostate cancer cells. Here, HDAC9 is linked to prostate carcinoma.